Publications by authors named "Cyra Leurs"

Claim this Profile
D
Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis - a multicentre study.
Harald Hegen, Klaus Berek, Paola Cavalla, Mikael Christiansen, Andreja Emeršič, Cyra Leurs

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and localization of early- and late-stage cancers using platelet RNA.
Sjors G J G In 't Veld, Mohammad Arkani, Edward Post, Mafalda Antunes-Ferreira, Silvia D'Ambrosi, Cyra E Leurs

Cancer Cell· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis.
Zoë Ygj van Lierop, Luuk Wieske, Marleen Ja Koel-Simmelink, Madhurima Chatterjee, Iris Dekker, Cyra E Leurs

Mult Scler· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teaching NeuroImage: Starch-Iodine Test: A Colorful Tool for Objectifying Anhidrosis in Horner Syndrome.
Govert Dwarshuis, Bastiaan Ter Meulen, Cyra Leurs, Harold Suliman

Neurology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
Claire Bridel, Cyra E Leurs, Zoë Y G J van Lierop, Zoé L E van Kempen, Iris Dekker

Neurology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis.
Claudia Sestito, Cyra E Leurs, Martijn D Steenwijk, John J P Brevé, Jos W R Twisk

Neurol Neuroimmunol Neuroinflamm· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic functional connectivity as a neural correlate of fatigue in multiple sclerosis.
Floris B Tijhuis, Tommy A A Broeders, Fernando A N Santos, Menno M Schoonheim, Joep Killestein, Cyra E Leurs

Neuroimage Clin· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Educated Platelet RNA for the Detection and (Pseudo)progression Monitoring of Glioblastoma.
Nik Sol, Sjors G J G In 't Veld, Adrienne Vancura, Maud Tjerkstra, Cyra Leurs

Cell Rep Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood platelet RNA enables the detection of multiple sclerosis.
Nik Sol, Cyra E Leurs, Sjors Gjg In 't Veld, Eva M Strijbis, Adrienne Vancura

Mult Scler J Exp Transl Clin· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma proteome in multiple sclerosis disease progression.
Arjan Malekzadeh, Cyra Leurs, Wessel van Wieringen, Martijn D Steenwijk, Menno M Schoonheim

Ann Clin Transl Neurol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients.
Cyra E Leurs, Zoé LE van Kempen, Iris Dekker, Lisanne J Balk, Mike P Wattjes

Mult Scler· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients.
Claire Bridel, Anand J C Eijlers, Wessel N van Wieringen, Marleen Koel-Simmelink, Cyra E Leurs

Front Mol Neurosci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of regional grey matter atrophy in multiple sclerosis.
Arman Eshaghi, Razvan V Marinescu, Alexandra L Young, Nicholas C Firth, Ferran Prados, Cyra E Leurs

Brain· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing.
Zoé LE van Kempen, Cyra E Leurs, Birgit I Witte, Annick de Vries, Mike P Wattjes

Mult Scler· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment.
Cyra E Leurs, Petar Podlesniy, Ramon Trullas, Lisanne Balk, Martijn D Steenwijk

Mult Scler· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Arman Eshaghi, Ferran Prados, Wallace J Brownlee, Daniel R Altmann, Carmen Tur, Cyra E Leurs

Ann Neurol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease activity following pregnancy-related discontinuation of natalizumab in MS.
Iris Kleerekooper, Zoé L E van Kempen, Cyra E Leurs, Iris Dekker, Theo Rispens

Neurol Neuroimmunol Neuroinflamm· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS.
Joep Killestein, Cyra E Leurs, Erwin L J Hoogervorst, Jeroen van Eijk, Jop P Mostert

Neurology· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.
Myron G Best, Nik Sol, Sjors G J G In 't Veld, Adrienne Vancura, Mirte Muller, Cyra Leurs

Cancer Cell· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations.
Zoé LE van Kempen, Cyra E Leurs, Anke Vennegoor, Mike P Wattjes, Theo Rispens

Mult Scler· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases.
Tamarah D de Jong, Saskia Vosslamber, Elise Mantel, Sander de Ridder, John G Wesseling, Cyra Leurs

Arthritis Res Ther· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body fluid biomarkers for multiple sclerosis--the long road to clinical application.
Charlotte E Teunissen, Arjan Malekzadeh, Cyra Leurs, Claire Bridel, Joep Killestein

Nat Rev Neurol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis